Trial Profile
Safety and efficacy of Glecaprevir / Pibrentasvir combination therapy for chronic hepatitis C - including hemodialysis patients -
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Apr 2018
At a glance
- Drugs Glecaprevir/pibrentasvir (Primary)
- Indications Hepatitis C; Liver cirrhosis
- Focus Therapeutic Use
- 04 Apr 2018 New trial record